Monday, March 30, 2020

Monday, March 30, 2020

FDA


Recent News About FDA View More

ARUVANT: Receives Orphan Drug Designation for ARU-1801 for the Treatment of Sickle Cell Disease

ARU-1801 is being developed as a potential one-time treatment for patients suffering from sickle cell disease and β-thalassemia

SK LIFE SCIENCE, INC.: Announces FDA Acceptance of IND Application for Anti-Epileptic Drug Candidate SKL24741

Acceptance of the IND application will allow the company to begin Phase I clinical trials for SKL24741 in 2020


FDA Health News